Generics
We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements of EDQM (CEP), ICH (EuDMF, CTD), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.
Amorphous
Therapeutic Area
Antifungal agent
Status
Pipeline
US DMF readiness
CAS No.
742049-41-8
Reference Product